NK - NantKwest Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 XLF (-0.8%) F (-0.89%) BTCUSD (%) AAPL (0.17%) APPS (-4.27%) EXPI (7.9%) FCEL (19.89%) FUTU (0.92%) IRBT (9.15%) MGNI (0.19%) NDAQ (-0.83%) PLUG (11.36%) REGI (-2%) SPWR (13.93%) XSPA (-1.54%) EVGN (6.07%) ETHUSD (%) ENDP (0.55%) ELY (-0.11%) DQ (5.99%) DGLY (8.27%) DAR (-0.97%) CVET (-4.42%) COWN (-1.95%) CLNE (-1.2%)

Recommendation

Service : Tech Trades | Trader : Tech Trades | Trade Date : 08/05/20

$NK - NantKwest

Buy Long

Trade

38.38 %

Target

$10.84

Issue Price

$15.00

Target Price

09/05/20

Target Date

$5.50

Stop Loss

Trade Closed - WINNER

Closed Position

Reason

12.08 %

P/L %

$12.15

Close Price

127

Days Held

12/11/20

Closed Date

To view trade details and get more recommendations from this trader Follow

NK - NantKwest

$19.14 0.13[0.69%]

15 mins delayed data

People also watch : MNTA | VGWCF | MTEM

+Watchlist

4 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$19.01	Open	$19.30
Volume	1.04M	Market Cap	2.064B
Yield		Last Dividend

Day

52 Week

RM LAW Announces Investigation of NantKw...	01/21/21
BERWYN, Pa. , Jan. 21, 2021 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of NantKwest, Inc. ("NantKwe...

J&J Opposes Former Talc Supplier???s Ban...	01/12/21
Imerys SA is pressing ahead in an effort to get out from under lawsuits over its U.S. mining operation, Imerys Talc America, over the protests of John...

NantKwest Executive Chairman Dr. Patrick...	01/06/21
EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced t...

NANTKWEST INVESTOR ALERT by the Former A...	12/29/20
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (???KSF???) a...

NantKwest Does Earnings Surprise History...	12/29/20
NantKwest announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by???

Insider Selling: NantKwest, Inc. (NASDAQ...	12/29/20
NantKwest, Inc. (NASDAQ:NK) insider Barry J. Simon sold 130,000 shares of the firm???s stock in a transaction on Tuesday, December 22nd. The shares we...

NantKwest Merger Investigation: Halper S...	12/24/20
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of NantKwest, Inc. (NASDAQ:NK) and...

SHAREHOLDER ALERT: Monteverde & Associat...	12/23/20
NEW YORK, Dec. 23, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headqu...

ImmunityBio, NantKwest Announce Positive...	11/10/20
CULVER CITY, Calif. & EL SEGUNDO, Calif.--(BUSINESS WIRE)--ImmunityBio, a privately-held immunotherapy company, and NantKwest, Inc. (NASDAQ: NK), a cl...

NantKwest Names Richard Adcock Chief Exe...	10/26/20
EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today appointed h...

ImmunityBio, NantKwest Announce First Pa...	10/21/20
CULVER CITY, Calif. & EL SEGUNDO, Calif.--(BUSINESS WIRE)--ImmunityBio, a privately-held immunotherapy company, and NantKwest, Inc. (NASDAQ: NK), a cl...

Nantkwest (NASDAQ:NK) Raised to Hold at ...	10/19/20
BidaskClub upgraded shares of Nantkwest (NASDAQ:NK) from a sell rating to a hold rating in a report released on Friday, BidAskClub reports. Other anal...

CytRx Highlights Use of Licensed Drug Al...	10/13/20
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB:CYTR) (???CytRx??? or the ???Company???), a specialized biopharmaceutical company focused on re...

CytRx Highlights Use of Licensed Drug Al...	10/07/20
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (???CytRx??? or the ???Company???), a specialized biopharmaceutical company focused on r...

NantKwest, ImmunityBio Add Third-Line Co...	10/06/20
EL SEGUNDO, Calif. & CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics comp...

NantKwest to Present at the 7th Annual J...	09/21/20
EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced t...

NantKwest and ImmunityBio Sign Collabora...	08/24/20
EL SEGUNDO, Calif. & CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics comp...

Cord Blood Registry (CBR??) By Generate ...	08/10/20
LOS ANGELES, and EL SEGUNDO, Calif., Aug. 10, 2020 /PRNewswire/ -- CBR?? by Generate Life Sciences, the world's largest private newborn stem cell bank...

NantKwest : Cors Blood Registry (CBR??) ...	08/10/20
CBR to Provide Umbilical Cord-Derived Cellular Material to NantKwest for additional COVID-19 Clinical Trials Utilizing MSC Therapy Los Angeles, Calif....

The Daily Biotech Pulse: Opko Wins CDC C...	07/21/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abb...

The top healthcare dealmaker at RBC says...	07/14/20
There's a biotech bubble forming around companies riding news on coronavirus vaccines and treatments, a top healthcare banker told Business Insider. A...

The Daily Biotech Pulse: Ziopharm Starts...	07/10/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affi...

The race for coronavirus treatments and ...	07/01/20
The summer will be a critical time for the race to develop effective coronavirus treatments and vaccines. Business Insider identified the nine most im...

ViewRay and NantKwest among healthcare g...	06/30/20
Gainers: Calliditas Therapeutics (NASDAQ:CALT) +20%. ViewRay (NASDAQ:VRAY) +19%. Anixa Biosciences (NASDAQ:ANIX) +19%. OptiNose (NASDAQ:OPTN) +18%. Na...

NantKwest Announces Closing of $90.7 Mil...	06/29/20
NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, announced today the closing of its previously announce

Tiny biotechs are touting ties to Trump'...	06/26/20
The Trump administration's coronavirus vaccine program, called Operation Warp Speed, has been shrouded in secrecy since launching in May. Some tiny bi...

NantKwest Announces Pricing of Public Of...	06/25/20
EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced t...

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $NK

Service Name	Trader	% Success
Big Data Zhou	Zhou Academy	82.00 %	Subscribe
Tech Trades	Tech Trades	81.00 %	Follow
WIDE AWAKE	JOHN KROLIKOWSKI JR	80.00 %	Follow
Arbitrage Trade Analytics	Royce Wells	71.00 %	Subscribe
FEAT. KENNY G	JOHN KROLIKOWSKI JR	49.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.